NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM
Delisted
NDRM was delisted on the 17th of October, 2017.
81 hedge funds and large institutions have $501M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 73 → 81 (+8)
17% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $2.83M
Holders
81
Holding in Top 10
3
Calls
$2.35M
Puts
$2.83M
Top Buyers
| 1 | +$53.3M | |
| 2 | +$43.9M | |
| 3 | +$43.4M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$28.7M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$22.9M |
Top Sellers
| 1 | -$163M | |
| 2 | -$24.2M | |
| 3 | -$23.2M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$21.2M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$19M |